Search Page

1

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Nitulescu GM, et al. Among authors: Moschos SA. Int J Mol Med. 2020 May 18. doi: 10.3892/ijmm.2020.4608. Online ahead of print. Int J Mol Med. 2020. PMID: 32468014

Cite

Share

2

A new threat from an old enemy: Re‑emergence of coronavirus (Review).

Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. Docea AO, et al. Among authors: Moschos SA. Int J Mol Med. 2020 Jun;45(6):1631-1643. doi: 10.3892/ijmm.2020.4555. Epub 2020 Mar 27. Int J Mol Med. 2020. PMID: 32236624 Free PMC article.

Cite

Share

3

Predicting oligonucleotide therapeutic efficacy at the population level.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: Moschos SA. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:182. Hell J Nucl Med. 2019. PMID: 31802060 Free article.

Cite

Share

4

RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting Therapeutics.

Usher L, Theotokis PI, Moschos SA. Usher L, et al. Among authors: Moschos SA. Methods Mol Biol. 2019;2036:283-305. doi: 10.1007/978-1-4939-9670-4_17. Methods Mol Biol. 2019. PMID: 31410804

Cite

Share

5

Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS).

Graves H, Evans S, Fauler M, Frick M, Moschos SA. Graves H, et al. Among authors: Moschos SA. Methods Mol Biol. 2019;2036:187-203. doi: 10.1007/978-1-4939-9670-4_11. Methods Mol Biol. 2019. PMID: 31410798

Cite

Share

6

Extracellular vesicles and their nucleic acids for biomarker discovery.

Momen-Heravi F, Getting SJ, Moschos SA. Momen-Heravi F, et al. Among authors: Moschos SA. Pharmacol Ther. 2018 Dec;192:170-187. doi: 10.1016/j.pharmthera.2018.08.002. Epub 2018 Aug 3. Pharmacol Ther. 2018. PMID: 30081050 Review.

Cite

Share

7

A novel antifungal property for the Bacillus licheniformis ComX pheromone and its possible role in inter-kingdom cross-talk.

Esmaeilishirazifard E, Dariush A, Moschos SA, Keshavarz T. Esmaeilishirazifard E, et al. Among authors: Moschos SA. Appl Microbiol Biotechnol. 2018 Jun;102(12):5197-5208. doi: 10.1007/s00253-018-9004-7. Epub 2018 Apr 23. Appl Microbiol Biotechnol. 2018. PMID: 29687141

Cite

Share

8

Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: Moschos SA. Mol Ther Nucleic Acids. 2017 Dec 15;9:22-33. doi: 10.1016/j.omtn.2017.08.010. Epub 2017 Aug 24. Mol Ther Nucleic Acids. 2017. PMID: 29246301 Free PMC article.

Cite

Share

9

Oligonucleotide Therapies for the Lung: Ready to Return to the Clinic?

Kumar M, Moschos SA. Kumar M, et al. Among authors: Moschos SA. Mol Ther. 2017 Dec 6;25(12):2604-2606. doi: 10.1016/j.ymthe.2017.11.002. Epub 2017 Nov 23. Mol Ther. 2017. PMID: 29174842 Free PMC article. No abstract available.

Cite

Share

10

Field-deployable, quantitative, rapid identification of active Ebola virus infection in unprocessed blood.

Shah K, Bentley E, Tyler A, Richards KSR, Wright E, Easterbrook L, Lee D, Cleaver C, Usher L, Burton JE, Pitman JK, Bruce CB, Edge D, Lee M, Nazareth N, Norwood DA, Moschos SA. Shah K, et al. Among authors: Moschos SA. Chem Sci. 2017 Nov 1;8(11):7780-7797. doi: 10.1039/c7sc03281a. Epub 2017 Sep 25. Chem Sci. 2017. PMID: 29163915 Free PMC article.

Cite

Share